NYSE:CHE - Chemed Stock Price, Price Target & More

$301.59 -1.26 (-0.42 %)
(As of 04/23/2018 01:07 PM ET)
Previous Close$302.85
Today's Range$300.44 - $305.26
52-Week Range$184.61 - $313.25
Volume61,390 shs
Average Volume108,266 shs
Market Capitalization$4.89 billion
P/E Ratio56.54
Dividend Yield0.38%
Beta1.05

About Chemed (NYSE:CHE)

Chemed logoChemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The VITAS segment offers direct medical services, as well as spiritual and emotional counseling services to terminally ill patients. This segment offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and operated territories, independent contractor-operated territories, and franchised locations. This segment also manufactures and sells products and equipment, including drain cleaning machines and drain cleaning solutions. The company was founded in 1970 and is headquartered in Cincinnati, Ohio.

Receive CHE News and Ratings via Email

Sign-up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
SymbolNYSE:CHE
CUSIP16359R10
Phone513-762-6690

Debt

Debt-to-Equity Ratio0.26%
Current Ratio0.91%
Quick Ratio0.88%

Price-To-Earnings

Trailing P/E Ratio56.54
Forward P/E Ratio28.13
P/E Growth2.83

Sales & Book Value

Annual Sales$1.67 billion
Price / Sales2.92
Cash Flow$7.9366 per share
Price / Cash38.00
Book Value$33.84 per share
Price / Book8.91

Profitability

EPS (Most Recent Fiscal Year)$5.36
Net Income$98.17 million
Net Margins6.67%
Return on Equity33.05%
Return on Assets17.97%

Miscellaneous

Employees14,813
Outstanding Shares16,160,000

How to Become a New Pot Stock Millionaire

Chemed (NYSE:CHE) Frequently Asked Questions

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed announced a quarterly dividend on Friday, February 16th. Investors of record on Monday, February 26th will be given a dividend of $0.28 per share on Monday, March 19th. This represents a $1.12 dividend on an annualized basis and a yield of 0.37%. The ex-dividend date of this dividend is Friday, February 23rd. View Chemed's Dividend History.

How will Chemed's stock buyback program work?

Chemed announced that its board has initiated a share repurchase plan on Wednesday, March 7th 2018, which authorizes the company to buyback $150,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to purchase shares of its stock through open market purchases. Shares buyback plans are usually an indication that the company's leadership believes its shares are undervalued.

How were Chemed's earnings last quarter?

Chemed Corp. (NYSE:CHE) issued its earnings results on Thursday, April, 19th. The company reported $2.72 EPS for the quarter, topping the Zacks' consensus estimate of $2.36 by $0.36. The company had revenue of $439.18 million for the quarter, compared to analysts' expectations of $419.33 million. Chemed had a net margin of 6.67% and a return on equity of 33.05%. The business's quarterly revenue was up 8.2% compared to the same quarter last year. During the same period in the previous year, the company earned $1.82 EPS. View Chemed's Earnings History.

When is Chemed's next earnings date?

Chemed is scheduled to release their next quarterly earnings announcement on Tuesday, July, 24th 2018. View Earnings Estimates for Chemed.

What guidance has Chemed issued on next quarter's earnings?

Chemed issued an update on its FY18 earnings guidance on Thursday, April, 19th. The company provided EPS guidance of $10.60-10.85 for the period, compared to the Thomson Reuters consensus EPS estimate of $10.72.

What price target have analysts set for CHE?

3 analysts have issued 12-month target prices for Chemed's stock. Their forecasts range from $258.00 to $275.00. On average, they anticipate Chemed's stock price to reach $266.50 in the next year. View Analyst Ratings for Chemed.

Who are some of Chemed's key competitors?

Who are Chemed's key executives?

Chemed's management team includes the folowing people:
  • Mr. Kevin J. McNamara, Pres, CEO & Director (Age 64)
  • Mr. David P. Williams, Exec. VP & CFO (Age 57)
  • Mr. Spencer S. Lee, Exec. VP (Age 62)
  • Mr. Nicholas Michael Westfall, Exec. VP (Age 39)
  • Mr. Timothy S. O'Toole, Consultant (Age 62)

Has Chemed been receiving favorable news coverage?

News headlines about CHE stock have been trending somewhat positive on Monday, Accern Sentiment Analysis reports. Accern rates the sentiment of news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Chemed earned a media sentiment score of 0.09 on Accern's scale. They also assigned news stories about the company an impact score of 46.32 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near term.

Who are Chemed's major shareholders?

Chemed's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include GAMCO INVESTORS, INC. ET AL (4.28%). Company insiders that own Chemed stock include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Institutional Ownership Trends for Chemed.

How do I buy shares of Chemed?

Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $301.59.

How big of a company is Chemed?

Chemed has a market capitalization of $4.89 billion and generates $1.67 billion in revenue each year. The company earns $98.17 million in net income (profit) each year or $5.36 on an earnings per share basis. Chemed employs 14,813 workers across the globe.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.


MarketBeat Community Rating for Chemed (CHE)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  146 (Vote Outperform)
Underperform Votes:  214 (Vote Underperform)
Total Votes:  360
MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe CHE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHE will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Chemed (NYSE:CHE) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Chemed in the last 12 months. Their average twelve-month price target is $266.50, suggesting that the stock has a possible downside of 11.64%. The high price target for CHE is $275.00 and the low price target for CHE is $258.00. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.332.332.332.50
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $266.50$266.50$228.50$214.50
Price Target Upside: 11.64% downside4.40% upside2.63% upside5.41% upside

Chemed (NYSE:CHE) Consensus Price Target History

Price Target History for Chemed (NYSE:CHE)

Chemed (NYSE:CHE) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/16/2018OppenheimerBoost Price TargetOutperform$270.00 -> $275.00LowView Rating Details
2/16/2018Royal Bank of CanadaReiterated RatingHold$258.00LowView Rating Details
10/27/2017KeyCorpReiterated RatingHoldN/AView Rating Details
8/13/2017National Bank FinancialUpgradeSector Perform Market Weight -> Outperform Market WeightN/AView Rating Details
9/4/2016JMP SecuritiesReiterated RatingHoldN/AView Rating Details
(Data available from 4/23/2016 forward)

Earnings

Chemed (NYSE:CHE) Earnings History and Estimates Chart

Earnings by Quarter for Chemed (NYSE:CHE)

Chemed (NYSE:CHE) Earnings Estimates

2018 EPS Consensus Estimate: $8.61
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$1.95$1.95$1.95
Q2 20181$2.09$2.09$2.09
Q3 20181$2.14$2.14$2.14
Q4 20181$2.43$2.43$2.43

Chemed (NYSE CHE) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/24/2018        
4/19/2018Q1 2018$2.36$2.72$419.33 million$439.18 millionViewN/AView Earnings Details
2/14/2018Q4 2017$2.27$2.32$423.83 million$428.35 millionViewListenView Earnings Details
10/26/2017Q3 2017$2.00$2.15$414.34 million$417.40 millionViewN/AView Earnings Details
7/25/2017Q2 2017$1.89$2.15$407.56 million$415.06 millionViewN/AView Earnings Details
4/26/2017Q1 2017$1.78$1.82$399.75 million$405.90 millionViewN/AView Earnings Details
2/15/2017Q416$2.10$2.10$409.89 million$403.00 millionViewListenView Earnings Details
10/26/2016Q316$1.82$1.73$270.44 million$392.61 millionViewListenView Earnings Details
7/25/2016Q216$1.72$1.80$393.50 million$290.00 millionViewListenView Earnings Details
4/28/2016Q116$1.58$1.62$391.68 million$390.40 millionViewListenView Earnings Details
2/17/2016Q415$1.81$1.97$390.22 million$398.60 millionViewListenView Earnings Details
10/22/2015Q315$1.61$1.78$375.95 million$386.23 millionViewListenView Earnings Details
7/23/2015Q215$1.59$1.71$375.01 million$382.00 millionViewListenView Earnings Details
4/28/2015Q115$1.35$1.54$370.76 million$377.00 millionViewListenView Earnings Details
2/17/2015Q414$1.65$1.80$372.54 million$379.00 millionViewListenView Earnings Details
10/30/2014Q314$1.34$1.40$360.00 million$358.40 millionViewListenView Earnings Details
8/7/2014$0.32$0.30$319.70 million$310.06 millionViewN/AView Earnings Details
7/23/2014Q214$1.31$1.50$363.73 million$360.18 millionViewListenView Earnings Details
4/29/2014Q114$1.23$1.32$256.77 million$358.30 millionViewListenView Earnings Details
2/17/2014Q4 2013$1.40$356.02 million$348.60 millionViewN/AView Earnings Details
10/29/2013Q313$1.34$1.36$355.40 million$340.90 millionViewListenView Earnings Details
7/18/2013Q2 2013$1.33$1.44$368.06 million$357.00 millionViewListenView Earnings Details
4/18/2013Q1 2013$1.29$1.38$365.08 million$367.00 millionViewListenView Earnings Details
2/18/2013Q4 2012$1.15$1.57$355.31 million$369.00 millionViewListenView Earnings Details
10/29/2012Q312$1.35$1.28$360.50 million$354.00 millionViewN/AView Earnings Details
7/25/2012$1.26$1.26ViewN/AView Earnings Details
4/19/2012$1.25$1.21ViewN/AView Earnings Details
2/14/2012$1.48$1.45ViewN/AView Earnings Details
10/25/2011$1.15$1.20ViewN/AView Earnings Details
7/26/2011Q2 2011$1.07$1.01ViewN/AView Earnings Details
4/26/2011$0.98$1.07ViewN/AView Earnings Details
2/15/2011$1.05$0.98ViewN/AView Earnings Details
10/25/2010Q3 2010$0.93$0.97ViewN/AView Earnings Details
7/28/2010Q2 2010$0.91$0.92ViewN/AView Earnings Details
4/20/2010Q1 2010$0.91$0.89ViewN/AView Earnings Details
2/15/2010Q4 2009$0.94$1.00ViewN/AView Earnings Details
10/27/2009Q3 2009$0.89$0.90ViewN/AView Earnings Details
7/30/2009Q2 2009$0.83$0.90ViewN/AView Earnings Details
4/22/2009Q1 2009$0.84$0.94ViewN/AView Earnings Details
2/16/2009Q4 2008$0.92$0.93ViewN/AView Earnings Details
10/21/2008Q3 2008$0.76$0.79ViewN/AView Earnings Details
7/28/2008Q2 2008$0.72$0.73ViewN/AView Earnings Details
4/24/2008Q1 2008$0.85$0.69ViewN/AView Earnings Details
2/21/2008Q4 2007$0.87$0.92ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Chemed (NYSE:CHE) Dividend Information

Chemed pays an annual dividend of $1.12 per share, with a dividend yield of 0.37%. CHE's most recent quarterly dividend payment was Monday, March 19. The company has grown its dividend for the last 9 consecutive years and is increasing its dividend by an average of 8.70% each year. Chemed pays out 20.90% of its earnings out as a dividend.
Most Recent Dividend:3/19/2018
Annual Dividend:$1.12
Dividend Yield:0.37%
Dividend Growth:8.70% (3 Year Average)
Payout Ratio:20.90% (Trailing 12 Months of Earnings)
10.45% (Based on This Year's Estimates)
9.85% (Based on Next Year's Estimates)
Track Record:9 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Chemed (NYSE:CHE)

Chemed (NYSE:CHE) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/16/2018quarterly$0.280.41%2/23/20182/26/20183/19/2018
11/3/2017Quarterly$0.280.48%11/10/201711/13/201712/4/2017
9/22/2017Monthly$0.109/28/20179/29/201710/31/2017
8/23/2017Monthly$0.108/29/20178/31/20179/29/2017
8/4/2017quarterly$0.280.57%8/10/20178/14/20179/1/2017
7/21/2017Monthly$0.107/27/20177/31/20178/31/2017
6/22/2017Monthly$0.106/28/20176/30/20177/31/2017
5/15/2017Quarterly$0.260.51%5/23/20175/25/20176/14/2017
2/17/2017quarterly$0.260.59%2/23/20172/27/20173/20/2017
11/4/2016quarterly$0.260.76%11/9/201611/14/201612/5/2016
8/5/2016quarterly$0.260.72%8/11/20168/15/20169/2/2016
5/16/2016quarterly$0.240.76%5/24/20165/26/20166/15/2016
2/19/2016quarterly$0.240.75%2/25/20162/29/20163/21/2016
11/6/2015quarterly$0.240.63%11/12/201511/16/201512/7/2015
8/7/2015quarterly$0.240.63%8/13/20158/17/20159/4/2015
5/18/2015quarterly$0.220.71%5/26/20155/28/20156/17/2015
2/20/2015quarterly$0.220.77%2/26/20153/2/20153/23/2015
11/7/2014quarterly$0.220.81%11/13/201411/17/201412/8/2014
8/11/2014quarterly$0.220.88%8/14/20148/18/20149/13/2014
8/8/2014quarterly$0.228/14/20148/18/20149/3/2014
5/19/2014quarterly$0.200.91%5/27/20145/29/20146/18/2014
2/21/2014quarterly$0.200.94%2/27/20143/3/20143/24/2014
11/8/2013quarterly$0.201.13%11/14/201311/18/201312/9/2013
8/2/2013quarterly$0.201.1%8/8/20138/12/20139/3/2013
5/20/2013quarterly$0.181.05%5/28/20135/30/20136/19/2013
2/20/2013quarterly$0.180.92%2/28/20133/4/20133/22/2013
(Data available from 1/1/2013 forward)

Insider Trades

Chemed (NYSE CHE) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.82%
Institutional Ownership Percentage: 94.77%
Insider Trading History for Chemed (NYSE:CHE)
Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Chemed (NYSE CHE) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/1/2018Kevin J McnamaraInsiderSell6,000$258.00$1,548,000.00140,049View SEC Filing  
2/21/2018Naomi C DallobVPSell1,050$257.00$269,850.006,649View SEC Filing  
12/4/2017Michael D WitzemanVPSell1,000$250.00$250,000.003,334View SEC Filing  
11/29/2017David Patrick WilliamsInsiderSell11,000$241.28$2,654,080.0074,857View SEC Filing  
11/27/2017Naomi C DallobVPSell950$240.38$228,361.009,747View SEC Filing  
11/22/2017Spencer S LeeInsiderSell1,000$238.24$238,240.0034,809View SEC Filing  
11/16/2017Michael D WitzemanVPSell1,579$235.00$371,065.004,334View SEC Filing  
11/15/2017Kevin J McnamaraCEOSell5,000$232.59$1,162,950.00136,800View SEC Filing  
11/15/2017Spencer S LeeInsiderSell1,000$232.27$232,270.0035,809View SEC Filing  
11/13/2017Nicholas Michael WestfallInsiderSell10,000$231.00$2,310,000.0013,351View SEC Filing  
11/8/2017Naomi C DallobVPSell1,900$231.00$438,900.0010,426View SEC Filing  
11/2/2017Donald E SaundersDirectorSell500$227.75$113,875.0010,298View SEC Filing  
11/2/2017Spencer S LeeEVPSell1,000$228.45$228,450.0036,809View SEC Filing  
10/31/2017Kevin J McnamaraCEOSell10,000$223.42$2,234,200.00170,016View SEC Filing  
10/31/2017Naomi C DallobVPSell750$222.09$166,567.509,097View SEC Filing  
10/2/2017Patrick P GraceDirectorSell500$201.48$100,740.004,515View SEC Filing  
9/1/2017Spencer S LeeInsiderSell1,000$197.46$197,460.0037,809View SEC Filing  
7/28/2017Kevin J McnamaraInsiderSell15,000$201.16$3,017,400.00173,801View SEC Filing  
6/26/2017George J Walsh IIIDirectorBuy1,000$204.56$204,560.007,908View SEC Filing  
5/4/2017Donald E SaundersDirectorBuy94$205.59$19,325.469,886View SEC Filing  
5/3/2017Donald E SaundersDirectorSell400$204.85$81,940.009,886View SEC Filing  
5/2/2017Kevin J McnamaraInsiderSell4,000$205.11$820,440.00148,943View SEC Filing  
5/1/2017Spencer S LeeInsiderSell1,000$202.47$202,470.0039,147View SEC Filing  
3/3/2017Kevin J McnamaraInsiderSell7,000$181.74$1,272,180.00149,191View SEC Filing  
3/2/2017Arthur V Tucker JrVPSell2,266$181.00$410,146.001,800View SEC Filing  
2/27/2017Arthur V Tucker JrVPSell8,878$179.21$1,591,026.388,070View SEC Filing  
2/24/2017Kevin J McnamaraInsiderSell7,000$177.63$1,243,410.00160,010View SEC Filing  
11/28/2016Patrick P GraceDirectorSell400$148.53$59,412.004,597View SEC Filing  
11/14/2016Donald E SaundersDirectorSell500$149.56$74,780.0010,286View SEC Filing  
11/14/2016Spencer S LeeInsiderSell4,500$150.22$675,990.0035,367View SEC Filing  
10/31/2016Kevin J McnamaraInsiderSell10,000$138.40$1,384,000.00189,266View SEC Filing  
9/22/2016Spencer S LeeInsiderSell2,000$141.67$283,340.0039,867View SEC Filing  
8/8/2016Donald E SaundersDirectorSell500$144.32$72,160.0010,786View SEC Filing  
8/5/2016Arthur V Tucker JrVPSell4,500$144.28$649,260.007,734View SEC Filing  
8/4/2016Arthur V Tucker JrVPSell3,089$143.88$444,445.323,234View SEC Filing  
8/3/2016Kevin J McnamaraInsiderSell18,000$144.87$2,607,660.00163,266View SEC Filing  
5/16/2016Donald E SaundersDirectorBuy77$126.53$9,742.8111,209View SEC Filing  
3/21/2016Spencer S LeeEVPSell24,382$132.29$3,225,494.7862,087View SEC Filing  
1/27/2016Patrick P GraceDirectorSell50$138.98$6,949.004,522View SEC Filing  
12/11/2015David Patrick WilliamsCFOSell5,000$151.72$758,600.0036,968View SEC Filing  
11/24/2015Spencer S LeeEVPSell5,000$154.10$770,500.0043,405View SEC Filing  
11/6/2015Kevin J McnamaraCEOSell6,000$157.02$942,120.00167,736View SEC Filing  
10/27/2015Spencer S. LeeEVPSell4,000$153.64$614,560.0048,405View SEC Filing  
10/26/2015Kevin J. McnamaraCEOSell8,000$149.04$1,192,320.00173,736View SEC Filing  
8/24/2015David Patrick WilliamsCFOSell10,000$138.09$1,380,900.0029,268View SEC Filing  
5/15/2015Arthur V Tucker JrVPSell9,000$121.00$1,089,000.00View SEC Filing  
5/7/2015Kevin J McnamaraCEOSell8,000$120.82$966,560.00View SEC Filing  
3/6/2015Spencer S LeeEVPSell9,931$115.16$1,143,653.96View SEC Filing  
3/2/2015Timothy S OtooleEVPSell10,000$117.82$1,178,200.00View SEC Filing  
2/27/2015Arthur V Tucker JrVPSell7,000$116.80$817,600.00View SEC Filing  
2/24/2015Arthur V Tucker JrVPSell2,685$114.35$307,029.75View SEC Filing  
2/23/2015Spencer S LeeEVPSell10,000$113.18$1,131,800.00View SEC Filing  
2/20/2015Kevin J McnamaraCEOSell13,000$112.71$1,465,230.00View SEC Filing  
11/14/2014Timothy S OtooleEVPSell5,000$106.81$534,050.00View SEC Filing  
11/13/2014Spencer S LeeEVPSell10,000$108.38$1,083,800.00View SEC Filing  
11/4/2014Kevin J McnamaraCEOSell4,000$104.13$416,520.00View SEC Filing  
9/10/2014Spencer S LeeEVPSell2,000$105.80$211,600.00View SEC Filing  
9/8/2014David Patrick WilliamsCFOSell5,000$105.90$529,500.00View SEC Filing  
8/7/2014Kevin J McnamaraCEOSell5,000$100.05$500,250.00View SEC Filing  
7/25/2014Arthur V Tucker JrVPSell9,000$101.26$911,340.00View SEC Filing  
7/25/2014Kevin J McnamaraCEOSell10,000$101.00$1,010,000.00View SEC Filing  
5/15/2014Timothy OtooleEVPSell9,000$87.62$788,580.0031,170View SEC Filing  
5/5/2014Kevin McnamaraCEOSell5,000$85.05$425,250.00178,710View SEC Filing  
4/2/2014Spencer LeeEVPSell2,000$90.15$180,300.0065,848View SEC Filing  
3/19/2014Thomas HuttonVPSell2,201$88.36$194,480.3628,699View SEC Filing  
3/11/2014Timothy OtooleEVPSell6,000$86.60$519,600.0037,519View SEC Filing  
3/3/2014Kevin McnamaraCEOSell4,000$84.47$337,880.00178,616View SEC Filing  
2/28/2014Arthur Tucker, Jr.VPSell9,000$85.01$765,090.008,282View SEC Filing  
2/25/2014Arthur Tucker, Jr.VPSell8,461$83.80$709,031.808,282View SEC Filing  
2/20/2014Spencer LeeEVPSell2,000$82.51$165,020.0067,848View SEC Filing  
2/19/2014Kevin McnamaraCEOSell4,000$82.18$328,720.00182,616View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Chemed (NYSE CHE) News Headlines

Source:
DateHeadline
Chemeds (CHE) CEO Kevin McNamara on Q1 2018 Results - Earnings Call TranscriptChemed's (CHE) CEO Kevin McNamara on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - April 20 at 5:01 PM
Chemed Corporation (CHE) Tops Q1 EPS by 36c, Maintains GuidanceChemed Corporation (CHE) Tops Q1 EPS by 36c, Maintains Guidance
www.streetinsider.com - April 20 at 8:53 AM
Chemed (CHE) Beats on Q1 Earnings & Revenues, Retains ViewChemed (CHE) Beats on Q1 Earnings & Revenues, Retains View
www.msn.com - April 20 at 8:53 AM
Chemed (CHE) Posts Quarterly  Earnings Results, Beats Estimates By $0.48 EPSChemed (CHE) Posts Quarterly Earnings Results, Beats Estimates By $0.48 EPS
www.americanbankingnews.com - April 19 at 6:56 PM
Chemed beats by $0.36, beats on revenueChemed beats by $0.36, beats on revenue
seekingalpha.com - April 19 at 5:14 PM
Chemed Q1 top line up 8%; earnings up 51%Chemed Q1 top line up 8%; earnings up 51%
seekingalpha.com - April 19 at 5:14 PM
BRIEF-Chemed Corp Q1 GAAP Earnings Per Share $2.66BRIEF-Chemed Corp Q1 GAAP Earnings Per Share $2.66
www.reuters.com - April 19 at 5:14 PM
Chemed: 1Q Earnings SnapshotChemed: 1Q Earnings Snapshot
finance.yahoo.com - April 19 at 5:14 PM
Chemed Reports First-Quarter 2018 ResultsChemed Reports First-Quarter 2018 Results
finance.yahoo.com - April 19 at 5:14 PM
Chemed (CHE) Releases FY18 Earnings GuidanceChemed (CHE) Releases FY18 Earnings Guidance
www.americanbankingnews.com - April 19 at 5:08 PM
VITAS HEALTHCARE BRINGS EXPERTISE IN RISK MITIGATION AND VALUE-BASED CARE TO APG CONFERENCE IN SAN DIEGOVITAS HEALTHCARE BRINGS EXPERTISE IN RISK MITIGATION AND VALUE-BASED CARE TO APG CONFERENCE IN SAN DIEGO
finance.yahoo.com - April 18 at 4:57 PM
Chemed (CHE) Cut to "Hold" at BidaskClubChemed (CHE) Cut to "Hold" at BidaskClub
www.americanbankingnews.com - April 14 at 8:30 AM
Chemed (CHE) Set to Announce Earnings on ThursdayChemed (CHE) Set to Announce Earnings on Thursday
www.americanbankingnews.com - April 12 at 1:25 AM
Form DEF 14A CHEMED CORP For: May 21Form DEF 14A CHEMED CORP For: May 21
www.streetinsider.com - April 11 at 4:57 PM
VITAS HEALTHCARE REFERRALS MADE EASIER WITH HOSPICE APP’S FACE SHEETVITAS HEALTHCARE REFERRALS MADE EASIER WITH HOSPICE APP’S FACE SHEET
finance.yahoo.com - April 9 at 5:05 PM
Chemed (CHE) Stock Rating Reaffirmed by Royal Bank of CanadaChemed (CHE) Stock Rating Reaffirmed by Royal Bank of Canada
www.americanbankingnews.com - April 8 at 11:01 AM
Chemed (CHE) Upgraded by ValuEngine to "Buy"Chemed (CHE) Upgraded by ValuEngine to "Buy"
www.americanbankingnews.com - April 3 at 5:52 PM
Chemed (CHE) Rating Increased to A- at TheStreetChemed (CHE) Rating Increased to A- at TheStreet
www.americanbankingnews.com - April 2 at 9:42 PM
Royal Bank of Canada Boosts Chemed (CHE) Price Target to $232.00Royal Bank of Canada Boosts Chemed (CHE) Price Target to $232.00
www.americanbankingnews.com - April 2 at 8:04 PM
Chemed Co. (CHE) Receives Consensus Rating of "Hold" from AnalystsChemed Co. (CHE) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - April 2 at 1:46 AM
LHC Group (LHCG) & Chemed (CHE) Critical ReviewLHC Group (LHCG) & Chemed (CHE) Critical Review
www.americanbankingnews.com - April 1 at 1:36 AM
Critical Comparison: Chemed (CHE) versus BioTelemetry (BEAT)Critical Comparison: Chemed (CHE) versus BioTelemetry (BEAT)
www.americanbankingnews.com - March 18 at 1:04 AM
Chemed Corporation to Present at the Oppenheimer 28th Annual Healthcare ConferenceChemed Corporation to Present at the Oppenheimer 28th Annual Healthcare Conference
finance.yahoo.com - March 14 at 4:58 PM
Chemed Co. (CHE) Given Consensus Rating of "Hold" by BrokeragesChemed Co. (CHE) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - March 8 at 1:24 AM
Chemed (CHE) Declares Share Buyback PlanChemed (CHE) Declares Share Buyback Plan
www.americanbankingnews.com - March 7 at 11:49 AM
Chemed Corporation’s Board of Directors Authorizes an Additional $150 Million for Stock RepurchaseChemed Corporation’s Board of Directors Authorizes an Additional $150 Million for Stock Repurchase
finance.yahoo.com - March 6 at 4:54 PM
Chemed Co. (CHE) Stake Decreased by Formidable Asset Management LLCChemed Co. (CHE) Stake Decreased by Formidable Asset Management LLC
www.americanbankingnews.com - March 6 at 9:50 AM
Chemed Co. (CHE) Shares Sold by Schroder Investment Management GroupChemed Co. (CHE) Shares Sold by Schroder Investment Management Group
www.americanbankingnews.com - March 6 at 9:48 AM
26,005 Shares in Chemed Co. (CHE) Purchased by WINTON GROUP Ltd26,005 Shares in Chemed Co. (CHE) Purchased by WINTON GROUP Ltd
www.americanbankingnews.com - March 5 at 4:09 PM
State of Tennessee Treasury Department Decreases Position in Chemed Co. (CHE)State of Tennessee Treasury Department Decreases Position in Chemed Co. (CHE)
www.americanbankingnews.com - March 5 at 3:28 PM
Chemed Co. (CHE) Insider Sells $1,548,000.00 in StockChemed Co. (CHE) Insider Sells $1,548,000.00 in Stock
www.americanbankingnews.com - March 2 at 3:54 PM
Investec Asset Management LTD Sells 27,574 Shares of Chemed Co. (CHE)Investec Asset Management LTD Sells 27,574 Shares of Chemed Co. (CHE)
www.americanbankingnews.com - March 2 at 3:47 PM
Chemed Co. (CHE) Holdings Trimmed by Royce & Associates LPChemed Co. (CHE) Holdings Trimmed by Royce & Associates LP
www.americanbankingnews.com - March 2 at 10:44 AM
Fuller & Thaler Asset Management Inc. Acquires 8,600 Shares of Chemed Co. (CHE)Fuller & Thaler Asset Management Inc. Acquires 8,600 Shares of Chemed Co. (CHE)
www.americanbankingnews.com - March 1 at 10:50 AM
Sei Investments Co. Buys 9,473 Shares of Chemed Co. (CHE)Sei Investments Co. Buys 9,473 Shares of Chemed Co. (CHE)
www.americanbankingnews.com - March 1 at 9:22 AM
Chemed Co. (CHE) Shares Bought by BlackRock Inc.Chemed Co. (CHE) Shares Bought by BlackRock Inc.
www.americanbankingnews.com - March 1 at 5:08 AM
Teacher Retirement System of Texas Sells 247 Shares of Chemed Co. (CHE)Teacher Retirement System of Texas Sells 247 Shares of Chemed Co. (CHE)
www.americanbankingnews.com - February 28 at 5:07 PM
Chemed Co. (CHE) Shares Bought by Rhumbline AdvisersChemed Co. (CHE) Shares Bought by Rhumbline Advisers
www.americanbankingnews.com - February 28 at 7:52 AM
Chemed Co. (CHE) Holdings Lowered by Systematic Financial Management LPChemed Co. (CHE) Holdings Lowered by Systematic Financial Management LP
www.americanbankingnews.com - February 27 at 11:28 AM
Chemed Corp (CHE) Files 10-K for the Fiscal Year Ended on December 31, 2017Chemed Corp (CHE) Files 10-K for the Fiscal Year Ended on December 31, 2017
finance.yahoo.com - February 26 at 4:57 PM
Chemed Co. (CHE) Shares Sold by Martingale Asset Management L PChemed Co. (CHE) Shares Sold by Martingale Asset Management L P
www.americanbankingnews.com - February 26 at 2:41 PM
Eaton Vance Management Invests $19.97 Million in Chemed Co. (CHE)Eaton Vance Management Invests $19.97 Million in Chemed Co. (CHE)
www.americanbankingnews.com - February 26 at 2:38 PM
Chemed Co. (CHE) Shares Sold by Smith Asset Management Group LPChemed Co. (CHE) Shares Sold by Smith Asset Management Group LP
www.americanbankingnews.com - February 25 at 2:28 PM
California Public Employees Retirement System Sells 307 Shares of Chemed Co. (CHE)California Public Employees Retirement System Sells 307 Shares of Chemed Co. (CHE)
www.americanbankingnews.com - February 24 at 5:12 AM
Chemed Co. (CHE) VP Naomi C. Dallob Sells 1,050 SharesChemed Co. (CHE) VP Naomi C. Dallob Sells 1,050 Shares
www.americanbankingnews.com - February 21 at 12:31 PM
Chemed Co. (CHE) to Issue $0.28 Quarterly DividendChemed Co. (CHE) to Issue $0.28 Quarterly Dividend
www.americanbankingnews.com - February 16 at 2:36 PM
Chemed (CHE) Receives "Hold" Rating from Royal Bank of CanadaChemed (CHE) Receives "Hold" Rating from Royal Bank of Canada
www.americanbankingnews.com - February 16 at 11:24 AM
Oppenheimer Increases Chemed (CHE) Price Target to $275.00Oppenheimer Increases Chemed (CHE) Price Target to $275.00
www.americanbankingnews.com - February 16 at 11:24 AM
Chemed Corporation to Present at the 2018 RBC Capital Markets’ Global Healthcare ConferenceChemed Corporation to Present at the 2018 RBC Capital Markets’ Global Healthcare Conference
finance.yahoo.com - February 15 at 5:06 PM
Chemed Reports Fourth-Quarter 2017 ResultsChemed Reports Fourth-Quarter 2017 Results
finance.yahoo.com - February 15 at 6:58 AM

SEC Filings

Chemed (NYSE:CHE) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Chemed (NYSE:CHE) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Chemed (NYSE CHE) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.